Nephros, Inc. NEPH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.36% | 24.20% | 23.25% | 32.67% | 32.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.36% | 24.20% | 23.25% | 32.67% | 32.36% |
| Cost of Revenue | 29.18% | 31.35% | 31.46% | 31.72% | 24.90% |
| Gross Profit | 15.23% | 20.07% | 18.31% | 33.27% | 37.13% |
| SG&A Expenses | 13.14% | 17.84% | 18.99% | 17.25% | 4.15% |
| Depreciation & Amortization | -16.20% | -12.68% | -7.80% | 3.70% | -6.58% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.81% | 24.32% | 25.11% | 24.63% | 13.64% |
| Operating Income | 26.57% | 22.81% | -12.31% | 19,000.00% | 250.52% |
| Income Before Tax | 27.59% | 29.68% | -3.43% | 1,255.06% | 262.33% |
| Income Tax Expenses | -51.85% | -33.33% | -20.00% | -20.00% | -- |
| Earnings from Continuing Operations | 29.03% | 30.82% | -3.12% | 1,513.51% | 259.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.03% | 30.82% | -3.12% | 1,513.51% | 259.42% |
| EBIT | 26.57% | 22.81% | -12.31% | 19,000.00% | 250.52% |
| EBITDA | 23.00% | 19.46% | -11.69% | 802.10% | 296.65% |
| EPS Basic | 26.02% | 28.29% | -3.31% | 1,531.88% | 257.90% |
| Normalized Basic EPS | 24.72% | 27.19% | -3.74% | 1,292.16% | 260.36% |
| EPS Diluted | 29.90% | 29.29% | -6.67% | 21,060.00% | 240.11% |
| Normalized Diluted EPS | 23.09% | 24.28% | -6.65% | 1,268.63% | 258.38% |
| Average Basic Shares Outstanding | 1.56% | 1.13% | 0.75% | 0.86% | 0.76% |
| Average Diluted Shares Outstanding | 3.46% | 4.19% | 4.23% | 3.62% | 2.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |